Search
for
Sort by
Research 211–240 of 1000+
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Medical Therapies
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Treatment of lichen planopilaris with Janus kinase inhibitors
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Alopecia areata
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Modern Management Approaches for Alopecia Areata
- What’s new in the treatment of hair loss?
- Hair loss disorders (alopecias)
- Systemic immunotherapies
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Assessment and treatment of adolescent hair loss
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata